254 related articles for article (PubMed ID: 18367647)
1. Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL.
Matsuoka S; Oike Y; Onoyama I; Iwama A; Arai F; Takubo K; Mashimo Y; Oguro H; Nitta E; Ito K; Miyamoto K; Yoshiwara H; Hosokawa K; Nakamura Y; Gomei Y; Iwasaki H; Hayashi Y; Matsuzaki Y; Nakayama K; Ikeda Y; Hata A; Chiba S; Nakayama KI; Suda T
Genes Dev; 2008 Apr; 22(8):986-91. PubMed ID: 18367647
[TBL] [Abstract][Full Text] [Related]
2. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis.
Onoyama I; Tsunematsu R; Matsumoto A; Kimura T; de Alborán IM; Nakayama K; Nakayama KI
J Exp Med; 2007 Nov; 204(12):2875-88. PubMed ID: 17984302
[TBL] [Abstract][Full Text] [Related]
3. Self-renewal versus transformation: Fbxw7 deletion leads to stem cell activation and leukemogenesis.
Perry JM; Li L
Genes Dev; 2008 May; 22(9):1107-9. PubMed ID: 18451101
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability.
King B; Trimarchi T; Reavie L; Xu L; Mullenders J; Ntziachristos P; Aranda-Orgilles B; Perez-Garcia A; Shi J; Vakoc C; Sandy P; Shen SS; Ferrando A; Aifantis I
Cell; 2013 Jun; 153(7):1552-66. PubMed ID: 23791182
[TBL] [Abstract][Full Text] [Related]
5. Fbxw7 in cell cycle exit and stem cell maintenance: insight from gene-targeted mice.
Onoyama I; Nakayama KI
Cell Cycle; 2008 Nov; 7(21):3307-13. PubMed ID: 18948752
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo maintenance of hematopoietic stem cells by quiescence induction through Fbxw7α overexpression.
Iriuchishima H; Takubo K; Matsuoka S; Onoyama I; Nakayama KI; Nojima Y; Suda T
Blood; 2011 Feb; 117(8):2373-7. PubMed ID: 21190997
[TBL] [Abstract][Full Text] [Related]
7. Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver.
Onoyama I; Suzuki A; Matsumoto A; Tomita K; Katagiri H; Oike Y; Nakayama K; Nakayama KI
J Clin Invest; 2011 Jan; 121(1):342-54. PubMed ID: 21123947
[TBL] [Abstract][Full Text] [Related]
8. Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7.
Thompson BJ; Jankovic V; Gao J; Buonamici S; Vest A; Lee JM; Zavadil J; Nimer SD; Aifantis I
J Exp Med; 2008 Jun; 205(6):1395-408. PubMed ID: 18474632
[TBL] [Abstract][Full Text] [Related]
9. Chromosome instability underlies hematopoietic stem cell dysfunction and lymphoid neoplasia associated with impaired Fbw7-mediated cyclin E regulation.
Siu KT; Xu Y; Swartz KL; Bhattacharyya M; Gurbuxani S; Hua Y; Minella AC
Mol Cell Biol; 2014 Sep; 34(17):3244-58. PubMed ID: 24958101
[TBL] [Abstract][Full Text] [Related]
10. Skp1-Cullin-F-box (SCF)-type ubiquitin ligase FBXW7 negatively regulates spermatogonial stem cell self-renewal.
Kanatsu-Shinohara M; Onoyama I; Nakayama KI; Shinohara T
Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8826-31. PubMed ID: 24879440
[TBL] [Abstract][Full Text] [Related]
11. SCF(FBXW7)-mediated degradation of p53 promotes cell recovery after UV-induced DNA damage.
Galindo-Moreno M; Giráldez S; Limón-Mortés MC; Belmonte-Fernández A; Reed SI; Sáez C; Japón MÁ; Tortolero M; Romero F
FASEB J; 2019 Oct; 33(10):11420-11430. PubMed ID: 31337255
[TBL] [Abstract][Full Text] [Related]
12. Emerging roles for the FBXW7 ubiquitin ligase in leukemia and beyond.
Kourtis N; Strikoudis A; Aifantis I
Curr Opin Cell Biol; 2015 Dec; 37():28-34. PubMed ID: 26426760
[TBL] [Abstract][Full Text] [Related]
13. Fbxw7-dependent degradation of Notch is required for control of "stemness" and neuronal-glial differentiation in neural stem cells.
Matsumoto A; Onoyama I; Sunabori T; Kageyama R; Okano H; Nakayama KI
J Biol Chem; 2011 Apr; 286(15):13754-64. PubMed ID: 21349854
[TBL] [Abstract][Full Text] [Related]
14. Ablation of Fbxw7 eliminates leukemia-initiating cells by preventing quiescence.
Takeishi S; Matsumoto A; Onoyama I; Naka K; Hirao A; Nakayama KI
Cancer Cell; 2013 Mar; 23(3):347-61. PubMed ID: 23518349
[TBL] [Abstract][Full Text] [Related]
15. FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation.
Babaei-Jadidi R; Li N; Saadeddin A; Spencer-Dene B; Jandke A; Muhammad B; Ibrahim EE; Muraleedharan R; Abuzinadah M; Davis H; Lewis A; Watson S; Behrens A; Tomlinson I; Nateri AS
J Exp Med; 2011 Feb; 208(2):295-312. PubMed ID: 21282377
[TBL] [Abstract][Full Text] [Related]
16. NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.
Asnafi V; Buzyn A; Le Noir S; Baleydier F; Simon A; Beldjord K; Reman O; Witz F; Fagot T; Tavernier E; Turlure P; Leguay T; Huguet F; Vernant JP; Daniel F; Béné MC; Ifrah N; Thomas X; Dombret H; Macintyre E
Blood; 2009 Apr; 113(17):3918-24. PubMed ID: 19109228
[TBL] [Abstract][Full Text] [Related]
17. Sequential mutations in Notch1, Fbxw7, and Tp53 in radiation-induced mouse thymic lymphomas.
Jen KY; Song IY; Banta KL; Wu D; Mao JH; Balmain A
Blood; 2012 Jan; 119(3):805-9. PubMed ID: 22117044
[TBL] [Abstract][Full Text] [Related]
18. Distinct Interactions of EBP1 Isoforms with FBXW7 Elicits Different Functions in Cancer.
Wang Y; Zhang P; Wang Y; Zhan P; Liu C; Mao JH; Wei G
Cancer Res; 2017 Apr; 77(8):1983-1996. PubMed ID: 28209614
[TBL] [Abstract][Full Text] [Related]
19. Fbxw7 controls angiogenesis by regulating endothelial Notch activity.
Izumi N; Helker C; Ehling M; Behrens A; Herzog W; Adams RH
PLoS One; 2012; 7(7):e41116. PubMed ID: 22848434
[TBL] [Abstract][Full Text] [Related]
20. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
